Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study

Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/JMEDGENET-2018-105313
P932PMC publication ID6073911
P698PubMed publication ID29730597

P50authorUsha MenonQ55130377
Goska LeslieQ56855923
Ranjit ManchandaQ58217855
Paul D P PharoahQ61822938
Antonis C AntoniouQ89766295
Jonathan P TyrerQ91084019
Simon A GaytherQ91677076
Maria P IntermaggioQ114374949
Jatinderpal K KalsiQ114427279
Aleksandra Gentry-MaharajQ30001996
Susan J. RamusQ45906365
P2093author name stringAndy Ryan
Andrew Lee
Xin Yang
Ian Jacobs
Faiza Gaba
P2860cites workTen-year relative survival for epithelial ovarian cancerQ84852379
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesQ28388497
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerQ30252854
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.Q30724410
Evaluation of Penalized and Nonpenalized Methods for Disease Prediction with Large-Scale Genetic DataQ30992084
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionQ34394665
Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease riskQ34988777
Identification of six new susceptibility loci for invasive epithelial ovarian cancerQ35541663
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility LociQ35815958
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsQ35848518
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerQ36276527
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Population distribution of lifetime risk of ovarian cancer in the United StatesQ36966258
Recruitment to multicentre trials--lessons from UKCTOCS: descriptive studyQ36973956
Penalized Regression and Risk Prediction in Genome-Wide Association StudiesQ37384147
Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancerQ37657957
Commentary on changing the risk threshold for surgical prevention of ovarian cancerQ39209405
Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysisQ39209416
Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women.Q40467391
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).Q51129805
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
P304page(s)546-554
P577publication date2018-08-01
P1433published inJournal of Medical GeneticsQ14640281
P1476titleEvaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study
P478volume55

Reverse relations

cites work (P2860)
Q90051408Assessing thyroid cancer risk using polygenic risk scores
Q91755717Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients
Q92301110MicroRNA-106a-3p Induces Apatinib Resistance and Activates Janus-Activated Kinase 2 (JAK2)/Signal Transducer and Activator of Transcription 3 (STAT3) by Targeting the SOCS System in Gastric Cancer
Q90178650NGS analysis in Marfan syndrome spectrum: Combination of rare and common genetic variants to improve genotype-phenotype correlation analysis
Q103027570Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction
Q97524107Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Search more.